Unknown

Dataset Information

0

The levels of soluble cMET ectodomain in the blood of patients with ovarian cancer are an independent prognostic biomarker.


ABSTRACT: The tyrosine kinase mesenchymal-epithelial transition (cMET) is typically overexpressed in up to 75% of patients with ovarian cancer, and cMET overexpression has been associated with poor prognosis. The proteolytic release of the soluble cMET (sMET) ectodomain by metalloproteases, a process called ectodomain shedding, reflects the malignant potential of tumour cells. sMET can be detected in the human circulation and has been proposed as biomarker in several cancers. However, the clinical relevance of sMET in ovarian cancer as blood-based biomarker is unknown and was therefore investigated in this study. sMET levels were determined by enzyme-linked immunosorbent assay in a set of 432 serum samples from 85 healthy controls and 86 patients with ovarian cancer (87% FIGO III/IV). Samples were collected at primary diagnosis, at four longitudinal follow-up time points during the course of treatment and at disease recurrence. Although there was no significant difference between median sMET levels at primary diagnosis of ovarian cancer vs. healthy controls, increased sMET levels at primary diagnosis were an independent predictor of shorter PFS (HR = 0.354, 95% CI: 0.130-0.968, P = 0.043) and shorter OS (HR = 0.217, 95% CI: 0.064-0.734, P = 0.014). In the follow-up samples, sMET levels were prognostically most informative after the first three cycles of chemotherapy, with high sMET levels being an independent predictor of shorter PFS (HR = 0.245, 95% CI: 0.100-0.602, P = 0.002). This is the first study to suggest that sMET levels in the blood can be used as an independent prognostic biomarker for ovarian cancer. Patients at high risk of recurrence and with poor prognosis, as identified based on sMET levels in the blood, could potentially benefit from cMET-directed therapies or other targeted regimes, such as PARP inhibitors or immunotherapy.

SUBMITTER: Klotz DM 

PROVIDER: S-EPMC8410524 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6109090 | biostudies-other
| S-EPMC8685369 | biostudies-literature
| S-EPMC7261542 | biostudies-literature
| S-EPMC3662688 | biostudies-literature
| S-EPMC7824928 | biostudies-literature
| S-EPMC4250849 | biostudies-other
| S-EPMC3784549 | biostudies-other
| S-EPMC317312 | biostudies-literature
| S-EPMC4930124 | biostudies-literature
| S-EPMC8637578 | biostudies-literature